153 related articles for article (PubMed ID: 35326474)
1. 3D Melanoma Cocultures as Improved Models for Nanoparticle-Mediated Delivery of RNA to Tumors.
Schäfer MEA; Keller F; Schumacher J; Haas H; Vascotto F; Sahin U; Hafner M; Rudolf R
Cells; 2022 Mar; 11(6):. PubMed ID: 35326474
[TBL] [Abstract][Full Text] [Related]
2. Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma.
Grabbe S; Haas H; Diken M; Kranz LM; Langguth P; Sahin U
Nanomedicine (Lond); 2016 Oct; 11(20):2723-2734. PubMed ID: 27700619
[TBL] [Abstract][Full Text] [Related]
3. Tumor stroma-containing 3D spheroid arrays: A tool to study nanoparticle penetration.
Priwitaningrum DL; Blondé JG; Sridhar A; van Baarlen J; Hennink WE; Storm G; Le Gac S; Prakash J
J Control Release; 2016 Dec; 244(Pt B):257-268. PubMed ID: 27616660
[TBL] [Abstract][Full Text] [Related]
4. 3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation.
Sethi P; Jyoti A; Swindell EP; Chan R; Langner UW; Feddock JM; Nagarajan R; O'Halloran TV; Upreti M
Nanomedicine; 2015 Nov; 11(8):2013-23. PubMed ID: 26282381
[TBL] [Abstract][Full Text] [Related]
5. Effect of stroma on the behavior of temoporfin-loaded lipid nanovesicles inside the stroma-rich head and neck carcinoma spheroids.
Yakavets I; Francois A; Lamy L; Piffoux M; Gazeau F; Wilhelm C; Zorin V; Silva AKA; Bezdetnaya L
J Nanobiotechnology; 2021 Jan; 19(1):3. PubMed ID: 33407564
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of Nanomedicine in Tumor Spheroid as an
Roy SM; Garg V; Barman S; Ghosh C; Maity AR; Ghosh SK
Front Bioeng Biotechnol; 2021; 9():785937. PubMed ID: 34926430
[TBL] [Abstract][Full Text] [Related]
7. A Three-Dimensional
Swaminathan S; Cranston AN; Clyne AM
Tissue Eng Part C Methods; 2019 Oct; 25(10):609-618. PubMed ID: 31441384
[TBL] [Abstract][Full Text] [Related]
8. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
9. Autophagy plays a dual role during intracellular siRNA delivery by lipoplex and polyplex nanoparticles.
Song W; Ma Z; Zhang Y; Yang C
Acta Biomater; 2017 Aug; 58():196-204. PubMed ID: 28528119
[TBL] [Abstract][Full Text] [Related]
10. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
11. Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment.
Courau T; Bonnereau J; Chicoteau J; Bottois H; Remark R; Assante Miranda L; Toubert A; Blery M; Aparicio T; Allez M; Le Bourhis L
J Immunother Cancer; 2019 Mar; 7(1):74. PubMed ID: 30871626
[TBL] [Abstract][Full Text] [Related]
12. 3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles.
Daunys S; Janonienė A; Januškevičienė I; Paškevičiūtė M; Petrikaitė V
Adv Exp Med Biol; 2021; 1295():243-270. PubMed ID: 33543463
[TBL] [Abstract][Full Text] [Related]
13. Monitoring Translation Activity of mRNA-Loaded Nanoparticles in Mice.
Rosigkeit S; Meng M; Grunwitz C; Gomes P; Kreft A; Hayduk N; Heck R; Pickert G; Ziegler K; Abassi Y; Röder J; Kaps L; Vascotto F; Beissert T; Witzel S; Kuhn A; Diken M; Schuppan D; Sahin U; Haas H; Bockamp E
Mol Pharm; 2018 Sep; 15(9):3909-3919. PubMed ID: 30028629
[TBL] [Abstract][Full Text] [Related]
14. Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy.
Zhang X; Men K; Zhang Y; Zhang R; Yang L; Duan X
Int J Nanomedicine; 2019; 14():2733-2751. PubMed ID: 31118608
[No Abstract] [Full Text] [Related]
15. Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.
Billingsley MM; Singh N; Ravikumar P; Zhang R; June CH; Mitchell MJ
Nano Lett; 2020 Mar; 20(3):1578-1589. PubMed ID: 31951421
[TBL] [Abstract][Full Text] [Related]
16. In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients.
Schuurhuis DH; Verdijk P; Schreibelt G; Aarntzen EH; Scharenborg N; de Boer A; van de Rakt MW; Kerkhoff M; Gerritsen MJ; Eijckeler F; Bonenkamp JJ; Blokx W; van Krieken JH; Boerman OC; Oyen WJ; Punt CJ; Figdor CG; Adema GJ; de Vries IJ
Cancer Res; 2009 Apr; 69(7):2927-34. PubMed ID: 19318559
[TBL] [Abstract][Full Text] [Related]
17. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
Yang Y; Zhang M; Song H; Yu C
Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
[TBL] [Abstract][Full Text] [Related]
18. A Polymeric Nanoparticle Formulation for Targeted mRNA Delivery to Fibroblasts.
Rodrigues AF; Rebelo C; Simões S; Paulo C; Pinho S; Francisco V; Ferreira L
Adv Sci (Weinh); 2023 Feb; 10(5):e2205475. PubMed ID: 36529964
[TBL] [Abstract][Full Text] [Related]
19. Application of 3D cultured multicellular spheroid tumor models in tumor-targeted drug delivery system research.
Huang BW; Gao JQ
J Control Release; 2018 Jan; 270():246-259. PubMed ID: 29233763
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
